DEPO News Alert Depomed Inc (DEPO) 15.54 12/25/2014 10:24:55

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Depomed Inc (DEPO) 15.54 $DEPO

Depomed Has Returned 32.1% Since SmarTrend Recommendation (DEPO)
Comtex SmarTrend(R) - Mon Dec 22, 9:11AM CST
SmarTrend identified an Uptrend for Depomed (NASDAQ EPO) on August 11th, 2014 at $12.34. In approximately 4 months, Depomed has returned 32.09% as of today's recent price of $16.30.
DEPO: 15.54 (+0.38)

Depomed Shares Up 22.8% Since SmarTrend's Buy Recommendation (DEPO)
Comtex SmarTrend(R) - Fri Dec 12, 4:50PM CST
SmarTrend identified an Uptrend for Depomed (NASDAQ EPO) on August 11th, 2014 at $12.34. In approximately 4 months, Depomed has returned 22.77% as of today's recent price of $15.15.
DEPO: 15.54 (+0.38)

Depomed Products Are Broadly Covered For 2015
Clinically Sound Investor - at Seeking Alpha - Fri Dec 12, 9:33AM CST

DEPO: 15.54 (+0.38)

Shares of DEPO Up 30.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Dec 05, 11:06AM CST
SmarTrend identified an Uptrend for Depomed (NASDAQ EPO) on August 11th, 2014 at $12.34. In approximately 4 months, Depomed has returned 30.15% as of today's recent price of $16.06.
DEPO: 15.54 (+0.38)

Market Movers - Pharma Industry Stocks - Hospira, Perrigo, Auxilium Pharma, Depomed, and Endo Intl.
PR Newswire - Mon Dec 01, 8:05AM CST
Investor-Edge has initiated coverage on the following equities: Hospira Inc. (NYSE: HSP), Perrigo Company PLC (NYSE: PRGO), Auxilium Pharmaceuticals Inc. (NASDAQ: AUXL), Depomed Inc. (NASDAQ: DEPO), and Endo International PLC (NASDAQ: ENDP). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Friday, November 28, 2014, ended on a mixed note as the Dow Jones Industrial Average finished flat at 17,828.24 and the NASDAQ Composite closed at 4,791.63, up 0.09%. The S&P 500 finished the session 0.25% lower at 2,067.56. During the trading session, seven out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 803.65, up 0.58%, with the index advancing 8.95% in the previous three months. Register for your complimentary reports on these five stocks at:
ENDP: 72.10 (+0.34), PRGO: 166.11 (+1.96), AUXL: 34.40 (+0.18), DEPO: 15.54 (+0.38), HSP: 62.60 (-0.07)

Depomed Up 22.9% Since SmarTrend Uptrend Call (DEPO)
Comtex SmarTrend(R) - Thu Nov 20, 4:48PM CST
SmarTrend identified an Uptrend for Depomed (NASDAQ EPO) on August 11th, 2014 at $12.34. In approximately 3 months, Depomed has returned 22.93% as of today's recent price of $15.17.
DEPO: 15.54 (+0.38)

Depomed To Present At Piper Jaffray 26th Annual Healthcare Conference
PR Newswire - Thu Nov 20, 3:05PM CST
Depomed, Inc. (NASDAQ EPO) today announced that it will be presenting at the Piper Jaffray 26th Annual Healthcare Conference in New York City.
DEPO: 15.54 (+0.38)

How 7% Yielding PDL BioPharma Is Reinventing Itself
David Zanoni - at Seeking Alpha - Wed Nov 12, 7:26AM CST

DEPO: 15.54 (+0.38), PDLI: 7.61 (unch)

Depomed To Present At Stifel 2014 Healthcare Conference
PR Newswire - Wed Nov 12, 7:00AM CST
Depomed, Inc. (NASDAQ EPO) today announced that it will be presenting at the Stifel 2014 Healthcare Conference in New York City.
DEPO: 15.54 (+0.38)

INVESTOR ALERT: Class Action Lawsuit Against PDL BioPharma, Inc. Announced by Law Offices of Howard G. Smith
Business Wire - Mon Nov 10, 2:32PM CST
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed in the United States District Court for the District of Nevada on behalf of purchasers of the securities of PDL BioPharma, Inc. ("PDL BioPharma" or the "Company" (NASDAQ DLI) between November 6, 2013 and September 16, 2014, inclusive (the "Class Period" .
DEPO: 15.54 (+0.38), PDLI: 7.61 (unch)

DepoMed's (DEPO) CEO James Schoeneck on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Nov 05, 6:30PM CST

DEPO: 15.54 (+0.38)

Depomed beats Street 3Q forecasts
Automated Insights - Wed Nov 05, 4:42PM CST
NEWARK, Calif. (AP) _ Depomed Inc. (DEPO) on Wednesday reported third-quarter earnings of $6.5 million.
DEPO: 15.54 (+0.38)

Depomed beats by $0.07, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 3:47PM CST

DEPO: 15.54 (+0.38)

Depomed (DEPO) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Nov 05, 3:25PM CST

DEPO: 15.54 (+0.38)

Depomed Reports Third Quarter 2014 Financial Results
PR Newswire - Wed Nov 05, 3:05PM CST
Depomed, Inc. (Nasdaq: DEPO) today reported financial results and highlighted operational achievements for the quarter ended September 30, 2014.
DEPO: 15.54 (+0.38)

Notable earnings after Wednesday’s close
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 4:35PM CST

CXO: 99.86 (-0.04), CODI: 15.99 (-0.11), EXXI: 3.45 (-0.22), JCOM: 63.12 (-0.46), ATSG: 8.68 (-0.10), GPOR: 42.09 (+0.38), ENS: 61.66 (+0.36), ECYT: 6.33 (+0.24), ALNY: 93.52 (+0.97), KGC: 2.70 (+0.11), GSM: 16.23 (+0.24), BKD: 36.16 (-0.07), DK: 27.12 (-0.10), AR: 42.50 (-0.64), IL: 11.44 (-0.01), DVR: 0.14 (-0.08), IO: 2.80 (+0.05), DEPO: 15.54 (+0.38), ETE: 57.05 (+0.03), AVG: 20.25 (+0.18), CSOD: 36.66 (-0.14), GNW: 8.40 (+0.01), ECOL: 39.67 (-0.07), BWC: 30.30 (-0.16), CPE: 5.39 (+0.02), FNV: 48.03 (+1.22), CTL: 40.18 (-0.05), ASH: 119.40 (-0.48), ENSG: 45.38 (+0.01), CLR: 38.78 (-1.48), ACAS: 14.95 (+0.12), G: 19.18 (unch), BREW: 13.79 (+0.01), AWK: 53.76 (+0.59), CVG: 20.51 (-0.01), AREX: 6.98 (-0.11), HTCH: 3.60 (unch), ETP: 63.95 (+0.35), ABTL: 11.24 (-0.04), FMI: 23.99 (-0.10), DPM: 45.60 (+0.36), BCOR: 13.90 (-0.03), CDE: 5.11 (+0.31), DRYS: 1.20 (-0.04), KW: 25.58 (-0.07), BALT: 2.47 (-0.11), ATO: 55.58 (+0.90), EXAR: 10.35 (+0.19), ACLS: 2.47 (+0.04), INWK: 7.82 (-0.04), ALSK: 1.82 (-0.05), CF: 275.49 (-3.16), EFC: 20.20 (-0.55), BIOS: 6.37 (unch), DYN: 29.42 (+0.12), DATA: 88.76 (+0.04), ANDE: 55.10 (+0.35), HOLX: 26.89 (+0.10), CBS: 55.70 (-0.13)

23.7% Return Seen to Date on SmarTrend Depomed Call (DEPO)
Comtex SmarTrend(R) - Thu Oct 30, 9:18AM CDT
SmarTrend identified an Uptrend for Depomed (NASDAQ EPO) on August 11th, 2014 at $12.34. In approximately 3 months, Depomed has returned 23.66% as of today's recent price of $15.26.
DEPO: 15.54 (+0.38)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

GreenTree Faces Softer Rooms, Debt and NYSE Deadline

Updated Category News Views 34

A hotel operator can post positive earnings and still leave shareholders with a nasty headache, and GreenTree's third quarter is that kind of report. NYSE:GHG produced RMB243.0 million in revenue, down 22.2% from a year earlier, while net income slipped to RMB49.3 million from RMB59.0 million. This was not a one-line stumble. Room pricing, occupancy, franchise economics...

Continue Reading
Rock Gate Buys Aviation Niche Player Blast Deflectors

Updated Category News Views 135

Jet exhaust is not glamorous, but somebody has to keep it from battering everything nearby. Rock Gate Partners’ acquisition of Blast Deflectors, Inc. puts money behind one of those stubbornly unsexy industrial niches where engineering credibility matters far more than a flashy sales pitch. The transaction closed October 16, 2026, and Northborne Partners announced...

Continue Reading
CCAPP Holiday Training Targets Seasonal Recovery Strain

Updated Category News Views 53

December cheer has a nasty habit of hiding the people barely holding themselves together. CCAPP’s upcoming virtual workshop, Hope for the Holidays: Understanding Depression, Stress & Resilience During the Holiday Season, takes that uncomfortable reality seriously rather than treating it like a seasonal footnote. For behavioral health workers supporting people in...

Continue Reading
Alibaba Lawsuit Deadline Puts Disclosure Risk in Focus

Updated Category News Views 73

A calendar deadline is doing more work than any earnings headline for Alibaba shareholders this week. A securities class action notice says investors who bought or acquired Alibaba Group Holding Limited securities between May 23, 2024 and November 11, 2026 may seek appointment as lead plaintiff by January 19, 2027. That is a procedural milestone, not a verdict, and...

Continue Reading
Water Damage Coverage Has More Traps Than Homeowners Think

Updated Category News Views 36

A wet basement does not care one bit whether the water arrived dramatically or dripped in for months. That ugly distinction, though, can decide whether a homeowner has an insurance claim or a repair bill that lands with a thud. Kathy Thurmond-Edwards, an insurance expert in Memphis, Tennessee, lays out the dividing lines plainly: sudden pipe failures may be treated very...

Continue Reading
Cash Flow Discipline Is Where Business Growth Gets Real

Updated Category News Views 73

A full order book can still leave a company gasping at payroll. That is the unglamorous point behind the Nov. 20, 2026, HelloNation piece featuring Kimberly Furrh of Furrh & Associates PC in Lawton, Oklahoma. Owners love to talk about sales because sales are visible, flattering and easy to celebrate. Cash is less theatrical. It is also the thing that keeps the lights on...

Continue Reading
Dario's Personify Panel Puts Distribution Model in Focus

Updated Category News Views 246

A Partner Megaphone Is Not a Revenue Line Monday's virtual panel gives DarioHealth a useful stage, but investors should not confuse a conference microphone with a signed sales order. Erez Raphael is set to lead a November 23 discussion with Personify Health President Ed Liebowitz at the U.S. Bancorp | BTIG Tech-Enabled Healthcare Forum, running from noon to 12:50 p.m....

Continue Reading
HVAC’s $383.6 Billion Shift Is About More Than Units

Updated Category News Views 163

Server racks are turning cooling gear into a front-row industrial story, and that deserves more attention than the usual sleepy talk about replacement air conditioners. Frost & Sullivan projects the global HVAC equipment market will reach $383.6 billion by 2031, growing at a 7.0% compound annual rate from 2025. That is a sizable market, sure, but the more interesting...

Continue Reading
MTI Adds Aviation Veterans as Acorn Builds MRO Plan

Updated Category News Views 127

Two old hands entering a boardroom can matter more than another glossy growth slogan, especially in aircraft maintenance, where a delayed part can ground an airplane and turn a customer relationship sour in a hurry. MTI Aviation has added Tony DiSimone Sr. and Aviv Tzur to its board, a move announced November 20, 2026, after Acorn Capital Management took a majority...

Continue Reading
AlphaPoint's Approval Device Targets AI Attack Risk

Updated Category News Views 45

A Separate Screen May Be Worth More Than Another Patch AlphaPoint is taking a fairly old security instinct and aiming it at a very current headache: if the laptop is lying to the employee, do not let the laptop have the final say. Its newly introduced Approval Device is dedicated hardware with its own display, built to let authorized staff inspect and approve sensitive...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming Healthcare: ShiftMed Enhances Scheduling at UNC Health

Updated Category News Views 389

Introduction to ShiftMed Flex at UNC Health UNC Health is taking a significant step forward by implementing ShiftMed Flex, a transformative solution aimed at enhancing workforce efficiency throughout its network. This innovative AI-driven platform is designed to improve shift participation by better matching healthcare providers' schedules with available shifts,...

Continue Reading
Rivian's Q4 Financial Performance Sparks Investor Optimism

Updated Category News Views 168

Rivian's Strong Financial Performance Rivian Automotive stock has demonstrated significant resilience and growth recently. Investors are keen to understand the factors that are propelling RIVN stock upward. The latest quarterly earnings report has highlighted Rivian’s remarkable performance, which is robust evidence of the company's progress in the competitive electric...

Continue Reading
Purple Biotech's Innovative Advancements with CAPTN-3 Antibody Platform

Updated Category News Views 295

Exciting Developments in Cancer Treatment from Purple Biotech Purple Biotech, a clinical-stage company at the forefront of oncology, has made impressive strides in its novel tri-specific T cell and NK cell engager platform, known as CAPTN-3. This innovative approach demonstrates sustained tumor regression in an in-vivo model of triple-negative breast cancer and showcases...

Continue Reading
Raytron's Thermal Technology Enhances Robotaxi Safety in All Weather

Updated Category News Views 222

Raytron's Innovative Thermal Cameras for Autonomous Driving As advancements in technology reshape our transportation systems, one major player in the field is Raytron, a leader in infrared thermal imaging. A pressing challenge in the rollout of Level 4 (L4) robotaxis is ensuring safe operation in various climatic conditions, especially during extreme weather. With...

Continue Reading
Investors Urged to Join Centene Corporation Class Action Now

Updated Category News Views 116

Centene Corporation Faces Class Action Lawsuit Levi & Korsinsky, LLP has officially notified investors about a class action lawsuit targeting Centene Corporation. This lawsuit may affect shareholders who experienced losses due to alleged securities fraud. Centene Corporation, identified by its ticker CNC, is at the center of this legal action, which has drawn attention...

Continue Reading